Kite Pharma Names Regulatory VP

Los Angeles-based Kite Pharma announced this morning that it has named a new VP. The biotechnology company--which is developing treatments for cancer--said it has named Rizwana F. Sproule, Ph.D. as Vice President, Regulatory Affairs. Sproule was previously at Amgen, including serving as Executive Director, Therapeutic Area Head for Oncology Global Regulatory Affairs. She also served at SmithKline Beecham Pharmaceuticals.